{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:08:05Z","timestamp":1792728485253,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T00:00:00Z","timestamp":1657584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T00:00:00Z","timestamp":1657584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s12325-022-02215-0","type":"journal-article","created":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T07:05:04Z","timestamp":1657609504000},"page":"4146-4156","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Real-World Reductions in Healthcare Resource Utilization over 6\u00a0Months in Patients with Substance Use Disorders Treated with a Prescription Digital Therapeutic"],"prefix":"10.1007","volume":"39","author":[{"given":"Neel","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulton F.","family":"Velez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Colman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Kauffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Ruetsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Anastassopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Maricich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,12]]},"reference":[{"issue":"4","key":"2215_CR1","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1177\/09637214211026984","volume":"30","author":"KM Carroll","year":"2021","unstructured":"Carroll KM. The profound heterogeneity of substance use disorders: implications for treatment development. Curr Dir in Psychol Sci. 2021;30(4):358\u201364.","journal-title":"Curr Dir in Psychol Sci"},{"key":"2215_CR2","unstructured":"Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2020 National Survey on Drug Use and Health (HHS Publication No. PEP21-07-01-003, NSDUH Series H-56). 2020. https:\/\/www.samhsa.gov\/data\/. Accessed 28 Oct 2021."},{"key":"2215_CR3","unstructured":"Centers for Disease Control & Prevention. Mental health, substance use, and suicidal ideation during the COVID-19 pandemic. https:\/\/www.cdc.gov\/mmwr\/volumes\/69\/wr\/mm6932a1.htm. Accessed 9 Mar 2022."},{"key":"2215_CR4","unstructured":"Miller SC, Fielin DA, Rosenthal RN, Saitz R. The ASAM principles of addiction medicine. 6th ed. Philadelphia: Wolters Kluwer; 2018."},{"issue":"3","key":"2215_CR5","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jsat.2010.11.002","volume":"40","author":"BA Moore","year":"2011","unstructured":"Moore BA, Fazzino T, Garnet B, Cutter CJ, Barry DT. Computer-based interventions for drug use disorders: a systematic review. J Subst Abuse Treat. 2011;40(3):215\u201323.","journal-title":"J Subst Abuse Treat"},{"issue":"8","key":"2215_CR6","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1176\/appi.ajp.2011.10101443","volume":"168","author":"BD Kiluk","year":"2011","unstructured":"Kiluk BD, Sugarman DE, Nich C, et al. A methodological analysis of randomized clinical trials of computer-assisted therapies for psychiatric disorders: toward improved standards for an emerging field. Am J Psychiatry. 2011;168(8):790\u20139.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"2215_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsat.2013.08.010","volume":"46","author":"LA Marsch","year":"2014","unstructured":"Marsch LA, Carroll KM, Kiluk BD. Technology-based interventions for the treatment and recovery management of substance use disorders: a JSAT special issue. J Subst Abuse Treat. 2014;46(1):1\u20134.","journal-title":"J Subst Abuse Treat"},{"key":"2215_CR8","first-page":"528","volume-title":"Improving the quality of health care for mental and substance-use conditions","author":"Institute of Medicine","year":"2006","unstructured":"Institute of Medicine. Improving the quality of health care for mental and substance-use conditions. Washington, DC: The National Academies Press; 2006. p. 528."},{"issue":"2","key":"2215_CR9","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/add.14793","volume":"115","author":"SN Lappan","year":"2020","unstructured":"Lappan SN, Brown AW, Hendricks PS. Dropout rates of in-person psychosocial substance use disorder treatments: a systematic review and meta-analysis. Addiction. 2020;115(2):201\u201317.","journal-title":"Addiction"},{"key":"2215_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2020.106661","volume":"113","author":"BG Bergman","year":"2021","unstructured":"Bergman BG, Kelly JF, Fava M, Eden EA. Online recovery support meetings can help mitigate the public health consequences of COVID-19 for individuals with substance use disorder. Addict Behav. 2021;113: 106661.","journal-title":"Addict Behav"},{"issue":"9","key":"2215_CR11","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1176\/appi.ajp.2020.20040417","volume":"177","author":"PA Spagnolo","year":"2020","unstructured":"Spagnolo PA, Montemitro C, Leggio L. New challenges in addiction medicine: COVID-19 infection in patients with alcohol and substance use disorders\u2014the perfect storm. Am J Psychiatry. 2020;177(9):805\u20137.","journal-title":"Am J Psychiatry"},{"issue":"7","key":"2215_CR12","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1007\/s10597-021-00861-2","volume":"57","author":"T Molfenter","year":"2021","unstructured":"Molfenter T, Heitkamp T, Murphy AA, Tapscott S, Behlman S, Cody OJ. Use of telehealth in mental health (MH) services during and after COVID-19. Community Ment Health J. 2021;57(7):1244\u201351.","journal-title":"Community Ment Health J"},{"issue":"6","key":"2215_CR13","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1111\/add.15080","volume":"115","author":"J Marsden","year":"2020","unstructured":"Marsden J, Darke S, Hall W, et al. Mitigating and learning from the impact of COVID-19 infection on addictive disorders. Addiction. 2020;115(6):1007\u201310.","journal-title":"Addiction"},{"issue":"1","key":"2215_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/02791072.2020.1836435","volume":"53","author":"VE Horigian","year":"2021","unstructured":"Horigian VE, Schmidt RD, Feaster DJ. Loneliness, mental health, and substance use among US young adults during COVID-19. J Psychoactive Drugs. 2021;53(1):1\u20139.","journal-title":"J Psychoactive Drugs"},{"key":"2215_CR15","unstructured":"National Academies of Sciences Engineering and Medicine. Communities in action: pathways to health equity. National Academies Press; 2017. https:\/\/www.nap.edu\/catalog\/24624\/communities-in-action-pathways-to-health-equity. Accessed 8 Mar 2022."},{"issue":"3","key":"2215_CR16","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.0242","volume":"4","author":"C Peterson","year":"2021","unstructured":"Peterson C, Li M, Xu L, Mikosz CA, Luo F. Assessment of annual cost of substance use disorder in US hospitals. JAMA Netw Open. 2021;4(3): e210242.","journal-title":"JAMA Netw Open"},{"key":"2215_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpr.2021.102110","volume":"91","author":"CE Paquette","year":"2022","unstructured":"Paquette CE, Daughters SB, Witkiewitz K. Expanding the continuum of substance use disorder treatment: nonabstinence approaches. Clin Psychol Rev. 2022;91: 102110.","journal-title":"Clin Psychol Rev"},{"issue":"5","key":"2215_CR18","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/adb.12414","volume":"22","author":"K Charlet","year":"2017","unstructured":"Charlet K, Heinz A. Harm reduction-a systematic review on effects of alcohol reduction on physical and mental symptoms. Addict Biol. 2017;22(5):1119\u201359.","journal-title":"Addict Biol"},{"issue":"6","key":"2215_CR19","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/S0306-4603(02)00294-0","volume":"27","author":"GA Marlatt","year":"2002","unstructured":"Marlatt GA, Witkiewitz K. Harm reduction approaches to alcohol use: health promotion, prevention, and treatment. Addict Behav. 2002;27(6):867\u201386.","journal-title":"Addict Behav"},{"issue":"2","key":"2215_CR20","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s11606-020-06331-x","volume":"36","author":"K Witkiewitz","year":"2021","unstructured":"Witkiewitz K, Kranzler HR, Hallgren KA, et al. Stability of drinking reductions and long-term functioning among patients with alcohol use disorder. J Gen Intern Med. 2021;36(2):404\u201312.","journal-title":"J Gen Intern Med"},{"issue":"9","key":"2215_CR21","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1111\/add.12589","volume":"109","author":"LA Benishek","year":"2014","unstructured":"Benishek LA, Dugosh KL, Kirby KC, et al. Prize-based contingency management for the treatment of substance abusers: a meta-analysis. Addiction. 2014;109(9):1426\u201336.","journal-title":"Addiction"},{"issue":"11","key":"2215_CR22","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1111\/j.1360-0443.2006.01581.x","volume":"101","author":"M Prendergast","year":"2006","unstructured":"Prendergast M, Podus D, Finney J, Greenwell L, Roll J. Contingency management for treatment of substance use disorders: a meta-analysis. Addiction. 2006;101(11):1546\u201360.","journal-title":"Addiction"},{"issue":"1","key":"2215_CR23","doi-asserted-by":"publisher","DOI":"10.2196\/17662","volume":"8","author":"SE Lord","year":"2021","unstructured":"Lord SE, Campbell ANC, Brunette MF, et al. Workshop on implementation science and digital therapeutics for behavioral health. JMIR Ment Health. 2021;8(1): e17662.","journal-title":"JMIR Ment Health"},{"key":"2215_CR24","doi-asserted-by":"crossref","unstructured":"Budney AJ, Higgins ST. Therapy manuals for drug addiction, a community reinforcement plus vouchers approach: treating cocaine addiction. Rockville: National Institute on Drug Abuse; 1998.","DOI":"10.1037\/e597512007-001"},{"issue":"8","key":"2215_CR25","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1037\/adb0000287","volume":"31","author":"NM Petry","year":"2017","unstructured":"Petry NM, Alessi SM, Olmstead TA, Rash CJ, Zajac K. Contingency management treatment for substance use disorders: how far has it come, and where does it need to go? Psychol Addict Behav. 2017;31(8):897\u2013906.","journal-title":"Psychol Addict Behav"},{"issue":"2","key":"2215_CR26","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1037\/1064-1297.16.2.132","volume":"16","author":"WK Bickel","year":"2008","unstructured":"Bickel WK, Marsch LA, Buchhalter AR, Badger GJ. Computerized behavior therapy for opioid-dependent outpatients: a randomized controlled trial. Exp Clin Psychopharmacol. 2008;16(2):132\u201343.","journal-title":"Exp Clin Psychopharmacol"},{"issue":"1","key":"2215_CR27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jsat.2013.08.012","volume":"46","author":"LA Marsch","year":"2014","unstructured":"Marsch LA, Guarino H, Acosta M, et al. Web-based behavioral treatment for substance use disorders as a partial replacement of standard methadone maintenance treatment. J Subst Abuse Treat. 2014;46(1):43\u201351.","journal-title":"J Subst Abuse Treat"},{"issue":"6","key":"2215_CR28","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1037\/a0037496","volume":"82","author":"DR Christensen","year":"2014","unstructured":"Christensen DR, Landes RD, Jackson L, et al. Adding an internet-delivered treatment to an efficacious treatment package for opioid dependence. J Consult Clin Psychol. 2014;82(6):964\u201372.","journal-title":"J Consult Clin Psychol"},{"issue":"6","key":"2215_CR29","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1176\/appi.ajp.2014.13081055","volume":"171","author":"AN Campbell","year":"2014","unstructured":"Campbell AN, Nunes EV, Matthews AG, et al. Internet-delivered treatment for substance abuse: a multisite randomized controlled trial. Am J Psychiatry. 2014;171(6):683\u201390.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"2215_CR30","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1177\/0032885516636858","volume":"96","author":"M Chaple","year":"2016","unstructured":"Chaple M, Sacks S, McKendrick K, et al. A comparative study of the therapeutic education system for incarcerated substance-abusing offenders. Prison J. 2016;96(3):485\u2013508.","journal-title":"Prison J"},{"key":"2215_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108585","volume":"132","author":"HF Luderer","year":"2022","unstructured":"Luderer HF, Campbell ANC, Nunes EV, et al. Engagement patterns with a digital therapeutic for substance use disorders: correlations with abstinence outcomes. J Subst Abuse Treat. 2022;132: 108585.","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"2215_CR32","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1080\/08897077.2022.2060425","volume":"43","author":"Y Maricich","year":"2022","unstructured":"Maricich Y, Nunes EV, Campbell ANC, et al. Safety and efficacy of a digital therapeutic for substance use disorder: secondary analysis of data from a NIDA Clinical Trials Network Study. Subst Abuse. 2022;43(1):937\u201342.","journal-title":"Subst Abuse."},{"key":"2215_CR33","doi-asserted-by":"crossref","unstructured":"Xiong X, Braun S, Stitzer M, et al. Evaluation of real-world outcomes associated with use of a prescription digital therapeutic to treat substance use disorders. Am J Addict. 2022. (in press).","DOI":"10.1111\/ajad.13346"},{"issue":"3","key":"2215_CR34","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1177\/2168479018763591","volume":"52","author":"NA Dreyer","year":"2018","unstructured":"Dreyer NA. Advancing a framework for regulatory use of real-world evidence: when real is reliable. Ther Innov Regul Sci. 2018;52(3):362\u20138.","journal-title":"Ther Innov Regul Sci"},{"issue":"11","key":"2215_CR35","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1007\/s12325-018-0805-y","volume":"35","author":"L Blonde","year":"2018","unstructured":"Blonde L, Khunti K, Harris SB, Meizinger C, Skolnik NS. Interpretation and impact of real-world clinical data for the practicing clinician. Adv Ther. 2018;35(11):1763\u201374.","journal-title":"Adv Ther"},{"key":"2215_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108306","volume":"218","author":"A Arifkhanova","year":"2021","unstructured":"Arifkhanova A, McCormick Kraus E, et al. Estimating costs of hospitalizations associated with opioid use disorder or opioid misuse at a large, urban safety-net hospital-Denver, Colorado, 2017. Drug Alcohol Depend. 2021;218: 108306.","journal-title":"Drug Alcohol Depend"},{"key":"2215_CR37","unstructured":"Centers for Medicare and Medicaid Services (CMS). Medicare hospital outpatient prospective payment system addendum A, April 2020 file. 2020. https:\/\/www.cms.gov\/Medicare\/Medicare-Fee-For-Service-Payment\/HospitalOutpatientPPS\/Addendum-A-and-Addendum-B-Updates. Accessed 28 July 2020."},{"issue":"1","key":"2215_CR38","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12873-022-00573-0","volume":"22","author":"LW Suen","year":"2022","unstructured":"Suen LW, Davy-Mendez T, LeSaint KT, Riley ED, Coffin PO. Emergency department visits and trends related to cocaine, psychostimulants, and opioids in the United States, 2008\u20132018. BMC Emerg Med. 2022;22(1):19.","journal-title":"BMC Emerg Med"},{"issue":"1","key":"2215_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/nyas.14688","volume":"1508","author":"CM Jones","year":"2022","unstructured":"Jones CM, Houry D, Han B, Baldwin G, Vivolo-Kantor A, Compton WM. Methamphetamine use in the United States: epidemiological update and implications for prevention, treatment, and harm reduction. Ann N Y Acad Sci. 2022;1508(1):3\u201322.","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"2215_CR40","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/pam.22112","volume":"38","author":"JC Maclean","year":"2019","unstructured":"Maclean JC, Saloner B. The effect of public insurance expansions on substance use disorder treatment: evidence from the affordable care act. J Policy Anal Manage. 2019;38(2):366\u201393.","journal-title":"J Policy Anal Manage"},{"issue":"1","key":"2215_CR41","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/hec.3482","volume":"27","author":"B Saloner","year":"2018","unstructured":"Saloner B, Akosa Antwi Y, Maclean JC, Cook B. Access to health insurance and utilization of substance use disorder treatment: evidence from the affordable care act dependent coverage provision. Health Econ. 2018;27(1):50\u201375.","journal-title":"Health Econ"},{"issue":"1","key":"2215_CR42","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/ehjqcco\/qcaa084","volume":"7","author":"P Kiss","year":"2021","unstructured":"Kiss P, Carcel C, Hockham C, Peters SAE. The impact of the COVID-19 pandemic on the care and management of patients with acute cardiovascular disease: a systematic review. Eur Heart J Qual Care Clin Outcomes. 2021;7(1):18\u201327.","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"4","key":"2215_CR43","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1161\/STROKEAHA.120.032312","volume":"52","author":"AS Mariet","year":"2021","unstructured":"Mariet AS, Giroud M, Benzenine E, et al. Hospitalizations for stroke in France during the COVID-19 pandemic before, during, and after the national lockdown. Stroke. 2021;52(4):1362\u20139.","journal-title":"Stroke"},{"key":"2215_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2022.114521","volume":"311","author":"RM Pavarin","year":"2022","unstructured":"Pavarin RM, Fabbri C, De Ronchi D. COVID-19 hospitalization rates in individuals with substance or alcohol use disorders. Psychiatry Res. 2022;311: 114521.","journal-title":"Psychiatry Res"},{"issue":"4","key":"2215_CR45","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1001\/jamapsychiatry.2020.4402","volume":"78","author":"KM Holland","year":"2021","unstructured":"Holland KM, Jones C, Vivolo-Kantor AM, et al. Trends in US emergency department visits for mental health, overdose, and violence outcomes before and during the COVID-19 pandemic. JAMA Psychiat. 2021;78(4):372\u20139.","journal-title":"JAMA Psychiat"},{"issue":"Suppl 1","key":"2215_CR46","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1016\/j.drugalcdep.2012.05.005","volume":"125","author":"N Mulvaney-Day","year":"2012","unstructured":"Mulvaney-Day N, DeAngelo D, Chen CN, Cook BL, Alegria M. Unmet need for treatment for substance use disorders across race and ethnicity. Drug Alcohol Depend. 2012;125(Suppl 1):S44-50.","journal-title":"Drug Alcohol Depend"},{"key":"2215_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.107679","volume":"206","author":"CE Martin","year":"2020","unstructured":"Martin CE, Scialli A, Terplan M. Unmet substance use disorder treatment need among reproductive age women. Drug Alcohol Depend. 2020;206: 107679.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"2215_CR48","doi-asserted-by":"publisher","first-page":"107","DOI":"10.7205\/MILMED-D-12-00131","volume":"178","author":"A Golub","year":"2013","unstructured":"Golub A, Vazan P, Bennett AS, Liberty HJ. Unmet need for treatment of substance use disorders and serious psychological distress among veterans: a nationwide analysis using the NSDUH. Mil Med. 2013;178(1):107\u201314.","journal-title":"Mil Med"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-022-02215-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-022-02215-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-022-02215-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T10:38:30Z","timestamp":1676111910000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-022-02215-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,12]]},"references-count":48,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["2215"],"URL":"https:\/\/doi.org\/10.1007\/s12325-022-02215-0","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,12]]},"assertion":[{"value":"18 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}